Baird Financial Group’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4M Sell
167,834
-3,180
-2% -$61K 0.01% 851
2026
Q1
$3.01M Sell
171,014
-13,382
-7% -$269K ﹤0.01% 905
2025
Q4
$3.64M Sell
184,396
-13,425
-7% -$241K 0.01% 834
2025
Q3
$3.45M Sell
197,821
-18,540
-9% -$275K 0.01% 863
2025
Q2
$3.03M Buy
216,361
+180,018
+495% +$2.9M 0.01% 880
2025
Q1
$677K Buy
36,343
+8,351
+30% +$125K ﹤0.01% 1296
2024
Q4
$315K Buy
+27,992
New +$327K ﹤0.01% 1537

Other funds holding ALHC

Baird Financial Group's ALHC Position: Q2 2026 in Review

Baird Financial Group reduced its Alignment Healthcare (ALHC) stake by 1.9% in Q2 2026, selling an estimated $61K and leaving 167,834 shares worth $4M. The position accounts for 0.01% of the portfolio, ranked #851.

Baird Financial Group first reported a position in ALHC in Q4 2024 and has held it in 7 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Baird Financial Group held 167,834 shares of Alignment Healthcare worth $4M as of Q2 2026.
  • Baird Financial Group sold 3,180 Alignment Healthcare shares in Q2 2026, an estimated $61K.
  • Alignment Healthcare made up 0.01% of Baird Financial Group's portfolio in Q2 2026, its #851 holding.
  • Baird Financial Group first reported a position in Alignment Healthcare in Q4 2024 and has held it in 7 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.